MEDICA 2022 and COMPAMED 2022 Witness Notable Increase in Participation and Booked Areas
By LabMedica International staff writers Posted on 13 Nov 2022 |

The international leading medical trade fair MEDICA (Düsseldorf, Germany), and COMPAMED, the leading international trade fair for suppliers from the medical technology industry, are being held in Düsseldorf, Germany from Monday to Thursday (14 to 17 November 2022). Compared to last year, when the first in-person event re-launched after the wholly digital meeting in 2020, both events have seen a notable increase in participation and booked presentation areas. Almost the entire trade fair area has been taken.
Both events combined are once again offering a professional audience a comprehensive overview of the newest medical products and services for modern treatment in doctors’ offices and clinics, including all relevant process steps in product development and product manufacturing. The scope of novelties being presented at MEDICA ranges from laboratory technology and equipment to physiotherapy and orthopedic technology, convenience goods and consumables, up to high-tech medical solutions (i.e. diagnostic imaging, robotics) and health IT applications.
Microengineering, innovative coatings and materials, sensors, packaging technology or complete processing of individual orders, too, are part of the main focus of COMPAMED in Halls 8a and 8b. The International Microtechnology Business Network IVAM will be organizing the COMPAMED HIGH-TECH FORUM as well as a product market geared towards microtechnology as part of COMPAMED. The goal of the session for internationalization “Europe meets USA – High-Tech for Medical Devices” is to strengthen the cooperation between players from component manufacture, device manufacture and users from Europe and the U.S. An evolving trend among suppliers which has been favored by the COVID-19 pandemic is microfluidics as a key technology for patient-centered applications of laboratory diagnostics.
Apart from this product area involving so-called “point-of-care” diagnostics, the pandemic has also given a certain “booster” to the digitalization of the health care system in many countries. This is where the digitally driven start-up scene profits, which offers many options to present themselves to investors and a professional medical audience. Of special note is the MEDICA START-UP PARK (in Hall 12), for example. The shared booth has established itself over the years as a central meeting point for business and networking, and this year, it again counts around 40 participants. One of them is the German start-up Thericon which sees itself as the first company to give operating theatres a type of imaging that has been compiled and visually assembled from several different sources. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and its intuitive display aim to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. The scope of further news from start-ups stretches from a compact system for wireless monitoring of a fetus, new ophthalmoscopes as diagnostic aids for cancer or stroke, to a variety of solutions involving Artificial Intelligence (AI), for example for medical management of nutrition, creating electronic patient files, or even for pre-operative tests concerning the evaluation of cognitive disturbances.
Another special stage for start-ups is the MEDICA CONNECTED HEALTHCARE FORUM (also in Hall 12). The topics for the four-day forum program focus on applications for medical networks, on the health metaverse (VR/AR technologies), on AI and Big Data and also on robotics. Around a 100 chosen young companies will present their businesses on the forum stage, where the finals of the 11th MEDICA Start-up COMPETITION (14 Nov.) and the 14th Healthcare Innovation World Cup (13 Nov) will be among the highlights. A new addition to the MEDICA program in the midst of the physiotherapy themed segment is the MEDICA SPORTS HUB (in trade fair Hall 4). Throughout the duration of the trade fair, the professional audience is being invited to train and engage in a dialogue with some of the most successful Olympic athletes in German history: Heike Henkel (Olympic champion, world champion and world record holder in the high jump) and Lars Riedel (Olympic champion and multiple world champion in the discus). Short lectures by the Olympic athletes, talk sessions and also audience-participation sporting exercises have been planned to alternate every half hour on each day of the fair. The topics range from mental health, nutrition, team success to professional endurance training or even aspects of workplace health promotion.
Not only sports celebrities have announced their attendance at MEDICA 2022, the program of the forums and the parallel conferences also feature top-class speakers. For example, Federal Minister of Health Prof. Dr Karl Lauterbach will be taking part in the kick-off event of the 45th German Hospital Day (DKT), the annual leading event for the top management of German hospitals (14 Nov./CCD Ost). Stabilizing the financial situation of the public health insurers is one of the issues that will be addressed at the MEDICA ECON FORUM (in Hall 12), where Dr Andreas Gassen, Chairman of the National Association of Statutory Health Insurance Physicians (KBV) will also participate. The starting day (14 Nov.) will also offer exciting sessions, such as the one with Dr. Gottfried Ludewig, Senior Vice President T-Systems Health Industry, on the so-called "amazonisation" of the healthcare market by tech giants, including the question of the extent to which this development will also affect Germany. On the third day of the forum organized by Techniker Krankenkasse (16 Nov.), the North Rhine-Westphalian Minister for Labor, Health and Social Affairs, Karl-Josef Laumann, will be attending to address questions of future health policy in the Forum Dialogue. Also part of the MEDICA program will be the Conference on Disaster and Military Medicine DiMiMED and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science scene.
“At MEDICA 2022, we will be welcoming more than 4,400 presenting companies. At COMPAMED 2022, there will be around 700. We consider this increase of 40% for booked areas and many different participants from 70 nations as a huge sign of the trust across borders that is being placed in both events,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf, underscoring the importance of MEDICA and COMPAMED. “What the medical technology industry needs in turbulent times such as these are just these strong platforms for international exchange, joint ventures and business. Companies are seeing an increasing necessity to work jointly with their partners in supply and manufacturing to ensure delivery capacity in times when prices increase dramatically and construction parts are becoming sparse.”
Related Links:
MEDICA
Latest MEDICA 2022 News
- Bosch Demonstrates Vivalytic All-In-One PCR Analyzer at MEDICA 2022
- Biovendor Group Presents CLIA Solution for Complex Diagnostics at MEDICA 2022
- Diatron Exhibits Advanced Hematology and Clinical Chemistry Analyzers at MEDICA 2022
- Immundiagnostik AG Presents New PCR Test MutaPLEX RespiraScreen4_Diff_seqc at MEDICA 2022
- Eurotrol Presents the Future of Blood Gas Controls at MEDICA 2022
- Rhinomed Announces European Launch of Revolutionary New Swab for Testing Children for Respiratory Diseases
- Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes
- Cormay Diagnostics Introduces True 5+ DIFF Multi-Patented Hematology Solution at MEDICA 2022
- EDAN Takes its Solutions up a Notch at MEDICA 2022
- Bioneer Presents Near-Patient POC Molecular Diagnostic System at MEDICA 2022
- Rhinostics Features New RHINObot Automated Decapper at MEDICA 2022
- MP Biomedicals Exhibits Innovative POC, Screening and Confirmatory Tests at MEDICA 2022
- Oxford Immunotec Showcases Automated T-SPOT.TB Test at MEDICA 2022
- Boditech Highlights Automated Benchtop and Handheld Immunoassay Readers at MEDICA 2022
- Co-Diagnostics Introduces its CoPrimer Technology and Applications at MEDICA 2022
- Sentinel Diagnostics Presents New Fully Automated Sample to Result System for Diagnosis of Viral Infections
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read more
CSF Test Distinguishes Prion Disease from Other Causes of Rapidly Progressive Dementia
Rapidly progressive dementias are a category of dementia where patients experience a swift decline from the onset of symptoms to losing functional independence, typically within two years.... Read more
Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries
Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more
CRISPR-Based Test Diagnoses Life-Threatening Fungal Infection More Quickly
Pneumocystis jirovecii pneumonia (PJP) is a serious fungal infection that mainly affects children and those with weakened immune systems. Diagnosing PJP typically requires invasive procedures like bronchoalveolar... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more